{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:24:48Z","timestamp":1789680288496,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","seizure-journal.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.seizure.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T17:45:50Z","timestamp":1704390350000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Intranasal administration of antiseizure medications in chronic and emergency treatment: Hopes and challenges"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-8285","authenticated-orcid":false,"given":"Natalia","family":"Chmielewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Szyndler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.seizure.2024.01.003_bib0001","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"June","key":"10.1016\/j.seizure.2024.01.003_bib0002","first-page":"1","article-title":"The pharmacoresistant epilepsy: an overview on existant and new emerging therapies","volume":"12","author":"Fattorusso","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2024.01.003_bib0003","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"20","key":"10.1016\/j.seizure.2024.01.003_bib0004","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"issue":"JUL","key":"10.1016\/j.seizure.2024.01.003_bib0005","first-page":"1","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers","volume":"8","author":"Tang","year":"2017","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010233","article-title":"Translational considerations in the development of intranasal treatments for epilepsy","volume":"15","author":"Prentice","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.seizure.2024.01.003_bib0007","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00415-012-6741-x","article-title":"Olfactory bulb volume in patients with temporal lobe epilepsy","volume":"260","author":"Hummel","year":"2013","journal-title":"J Neurol"},{"issue":"May","key":"10.1016\/j.seizure.2024.01.003_bib0008","first-page":"1","article-title":"The piriform, perirhinal, and entorhinal cortex in seizure generation","volume":"9","author":"Vismer","year":"2015","journal-title":"Front Neural Circ"},{"issue":"DEC","key":"10.1016\/j.seizure.2024.01.003_bib0009","first-page":"1","article-title":"The piriform cortex and human focal epilepsy","volume":"5","author":"Vaughan","year":"2014","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.seizure.2024.01.003_bib0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl Res"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2024.01.003_bib0011","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2015.05.021","article-title":"Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice","volume":"490","author":"Serralheiro","year":"2015","journal-title":"Int J Pharm"},{"issue":"February","key":"10.1016\/j.seizure.2024.01.003_bib0012","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2019.04.047","article-title":"Nose-to-brain delivery of levetiracetam after intranasal administration to mice","volume":"564","author":"Gon\u00e7alves","year":"2019","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2024.01.003_bib0013","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","article-title":"Nanoparticles for direct nose-to-brain delivery of drugs","volume":"379","author":"Mistry","year":"2009","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.seizure.2024.01.003_bib0014","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.seizure.2024.01.003_bib0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/path.4461","article-title":"The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system","volume":"235","author":"Van Riel","year":"2015","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.seizure.2024.01.003_bib0016","first-page":"371","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J Perinatol"},{"issue":"3","key":"10.1016\/j.seizure.2024.01.003_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.seizure.2024.01.003_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122049","article-title":"Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier","volume":"13","author":"Lee","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0019","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajps.2017.09.001","article-title":"Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain","volume":"13","author":"Liu","year":"2018","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/neurolint13010007","article-title":"Valtoco\u00ae (Diazepam nasal spray) for the acute treatment of intermittent stereotypic episodes of frequent seizure activity","volume":"13","author":"Cornett","year":"2021","journal-title":"Neurol Int"},{"issue":"5","key":"10.1016\/j.seizure.2024.01.003_bib0021","first-page":"1","article-title":"Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review","volume":"10","author":"Cornett","year":"2022","journal-title":"Heal Psychol Res"},{"issue":"9","key":"10.1016\/j.seizure.2024.01.003_bib0022","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/epi.15159","article-title":"Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters\u2014a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Detyniecki","year":"2019","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.seizure.2024.01.003_bib0023","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/epi.17041","article-title":"Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy","volume":"62","author":"Wheless","year":"2021","journal-title":"Epilepsia"},{"issue":"May","key":"10.1016\/j.seizure.2024.01.003_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2014.04.019","article-title":"Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting","volume":"60","author":"Serralheiro","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.seizure.2024.01.003_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/17425247.2014.945416","article-title":"Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy","volume":"12","author":"Alam","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.seizure.2024.01.003_bib0026","unstructured":"Taksande et\u00a0al., \u201cFormulation and pharmacodynamic investigations of lamotrigine microspheres in pentylenetetrazole- induced seizures in mice,\u201d no. 1, pp. 215\u201324, 2017."},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0027","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/21691401.2021.1939709","article-title":"Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study","volume":"49","author":"Shah","year":"2021","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0028","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajps.2013.07.008","article-title":"Preparation and evaluation of transnasal microemulsion of carbamazepine","volume":"8","author":"Acharya","year":"2013","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0029","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10717544.2011.644349","article-title":"Carbamazepine Mucoadhesive Nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa","volume":"19","author":"Samia","year":"2012","journal-title":"Drug Deliv"},{"issue":"22","key":"10.1016\/j.seizure.2024.01.003_bib0030","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1039\/D1BM01251G","article-title":"Intranasal delivery of phenytoin-loaded nanoparticles to the brain suppresses pentylenetetrazol-induced generalized tonic clonic seizures in an epilepsy mouse model","volume":"9","author":"Yousfan","year":"2021","journal-title":"Biomater Sci"},{"issue":"4","key":"10.1016\/j.seizure.2024.01.003_bib0031","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40005-015-0190-3","article-title":"Development of phenytoin intranasal microemulsion for treatment of epilepsy","volume":"45","author":"Acharya","year":"2015","journal-title":"J Pharm Investig"},{"key":"10.1016\/j.seizure.2024.01.003_bib0032","first-page":"2021","article-title":"A combo-strategy to improve brain delivery of antiepileptic drugs: focus on BCRP and intranasal administration","volume":"593","author":"Gon\u00e7alves","year":"2020","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.seizure.2024.01.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-020-02786-z","article-title":"Pre-clinical assessment of the nose-to-brain delivery of zonisamide after intranasal administration","volume":"37","author":"Gon\u00e7alves","year":"2020","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.seizure.2024.01.003_bib0034","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10717544.2014.908980","article-title":"Microemulsion-based drug delivery system for transnasal delivery of Carbamazepine: preliminary brain-targeting study","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T03:11:31Z","timestamp":1738465891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":34,"alternative-id":["S1059131124000098"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.01.003","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of antiseizure medications in chronic and emergency treatment: Hopes and challenges","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}